<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="many studies of Momordica charantia (MC) in the treatment of" exact="diabetes mellitus" post="(DM) and its complications have been reported. This article"/>
 <result pre="China818743828190415881904011 1. Introduction Diabetes is a metabolic disease with typical" exact="hyperglycemia" post="manifestations, such as polydipsia, polyphagia, polyuria, impaired vision and"/>
 <result pre="2 diabetes (T2DM) (a gradual decrease in Î²-cell insulin secretion)," exact="gestational diabetes," post="and specific types of diabetes [3]. It is a"/>
 <result pre="system [7] gradually and has become the leading cause of" exact="kidney failure" post="[8] and blindness [9]. Insulin injection and oral hypoglycemic"/>
 <result pre="activation of IRS-1/PI3K/Akt pathway, leading to translocation of GLUT4 and" exact="suppression" post="of GSK-3Î², thereby stimulating glucose uptake by skeletal muscle"/>
 <result pre="Î±-glucosidase is performed in a dose-dependent manner [49]. Moreover, the" exact="suppression" post="of the ethyl acetate fraction of MC extract on"/>
 <result pre="1 (11Î²-HSD1) is currently recognized as an important cause of" exact="obesity" post="and type 2 diabetes epidemics. An experiment in vitro"/>
 <result pre="regulation of GLUT4 transport and glucose utilization, which conduce the" exact="hypoglycemia" post="of MC [95]. Moreover, the hypoglycemic activity of different"/>
 <result pre="secretion obviously [106]. In 2012, a study focused on 42" exact="metabolic syndrome" post="patients reported that bitter gourd treatment for three months"/>
 <result pre="gourd treatment for three months evidently decreased the incidence of" exact="metabolic syndrome," post="which is recognized for predicting T2DM, and the improvement"/>
 <result pre="subjects [108]. Next year, a RCT on 52 individuals with" exact="prediabetes" post="showed that MC intake dropped the blood glucose in"/>
 <result pre="above that, one observational study on incidence and reasons of" exact="hypoglycemia" post="in T2DM patients suggests that natural foods accounted for"/>
 <result pre="is also illustrated that MCP inhibits the exacerbation of diabetic" exact="nephropathy" post="by suppressing oxidative stress and regulating HO-1/Nrf2 pathway in"/>
 <result pre="in STZ-induced diabetic rats [81]. MC extract administration prolongs diabetic" exact="nephropathy" post="via protecting kidneys from oxidative damage [115]. On the"/>
 <result pre="extract [119]. A clinical RCT also confirms the improvement of" exact="dyslipidemia" post="by bitter melon hot water extract [120]. All of"/>
 <result pre="poisoning symptoms such as acute convulsions, nervous disorders, jumping, and" exact="shortness" post="of breath [127]. Besides, it is found that water"/>
 <result pre="Abbreviations MC: Momordica charantia DM: Diabetes mellitus T1DM: Type 1" exact="diabetes mellitus" post="T2DM: Type 2 diabetes mellitus GLUT: Translocation of glucose"/>
 <result pre="Diabetes mellitus T1DM: Type 1 diabetes mellitus T2DM: Type 2" exact="diabetes mellitus" post="GLUT: Translocation of glucose transporter IR: Insulin receptor mcIRBP:"/>
 <result pre="by plant extracts and their use in the treatment of" exact="diabetes mellitus;" post="discrepancies in effectiveness between animal and human studiesJournal of"/>
 <result pre="M.DeynoS.et al.Momordica charantia L. lowers elevated glycaemia in type 2" exact="diabetes mellitus" post="patients: systematic review and meta-analysisJournal of Ethnopharmacology201923131132410.1016/j.jep.2018.10.03330385422 26LoH.-Y.LiC.-C.ChenF.-Y.ChenJ.-C.HsiangC.-Y.HoT.-Y.Gastro-resistant insulin"/>
 <result pre="action of Momordica charantia juice in the treatment of streptozotocin-induced" exact="diabetes mellitus" post="in ratMolecular and Cellular Biochemistry20042611637010.1023/b:mcbi.0000028738.95518.9015362486 31Yibchok-AnunS.AdisakwattanaS.YaoC. Y.SangvanichP.RoengsumranS.HsuW. H.Slow acting"/>
 <result pre="regulating the expression of socs-3 and jnk in type 2" exact="diabetes mellitus" post="ratsPharmaceutical Biology20175512170217710.1080/13880209.2017.139635029110587 36YangS. J.ChoiJ. M.ParkS. E.et al.Preventive effects of"/>
 <result pre="Ethnopharmacology2011135115616110.1016/j.jep.2011.03.00121392566 47ShihC.-C.LinC.-H.LinW.-L.Effects of Momordica charantia on insulin resistance and visceral" exact="obesity" post="in mice on high-fat dietDiabetes Research and Clinical Practice200881213414310.1016/j.diabres.2008.04.02318550200"/>
 <result pre="blood glucose level and improved lipid profile of streptozotocin induced" exact="hyperglycemia" post="ratsCurrent Research in Nutrition and Food Science20186235937010.12944/crnfsj.6.2.11 61MalekshahiH.BahramiG.MiraghaeeS.et al.Momordica"/>
 <result pre="63ShihC. C.ShlauM. T.LinC. H.WuJ. B.Momordica charantia ameliorates insulin resistance and" exact="dyslipidemia" post="with altered hepatic glucose production and fatty acid synthesis"/>
 <result pre="al.Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic" exact="nephropathy" post="in ratsInternational Journal of Biological Macromolecules20169139439910.1016/j.ijbiomac.2016.05.09027238589 82WenJ. J.GaoH.HuJ. L.et"/>
 <result pre="Macromolecules20169139439910.1016/j.ijbiomac.2016.05.09027238589 82WenJ. J.GaoH.HuJ. L.et al.Polysaccharides from fermented Momordica charantia ameliorate" exact="obesity" post="in high-fat induced obese ratsFood and Function201910144845710.1039/c8fo01609g30628614 83BeukesN.LevendalR. A.FrostC."/>
 <result pre="stressCurrent Pharmaceutical Design201723162333234310.2174/138161282366617012414110428120728 85EsserN.Legrand-PoelsS.PietteJ.ScheenA. J.PaquotN.Inflammation as a link between obesity," exact="metabolic syndrome" post="and type 2 diabetesDiabetes Research and Clinical Practice2014105214115010.1016/j.diabres.2014.04.00624798950 86KoboriM.NakayamaH.FukushimaK.et"/>
 <result pre="fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in" exact="diabetes mellitus" post="(NIDDM)Indian Journal of Physiology and Pharmacology200448224124415521566 103RahmanI. U.MalikS. A.BashirM.KhanR.IqbalM.Serum"/>
 <result pre="and Pharmacology200448224124415521566 103RahmanI. U.MalikS. A.BashirM.KhanR.IqbalM.Serum sialic acid changes in non-insulin-dependant" exact="diabetes mellitus" post="(NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone"/>
</results>
